Best of ASCO® 2018 Miami Symposium

Registration closed. Walk-ins welcome on site.

July 13-14, 2018

JW Marriott Marquis Miami
255 Biscayne Boulevard Way
Miami, FL 33131


  • CAR T Cell Therapy for Hematology Malignancies
  • Liquid Biopsies) (from RT-PCR, CTCs, ddPCR to NGS)
  • Gastrointestinal Tumors (Pancreas, Liver, Colon)
  • Breast Cancer (Prevention, Treatment and Survivorship)
  • Lung Cancer (NSCLC and SCLC)
  • Hematology Malignancies and Bone Marrow Transplant
  • Gynecology-Oncology
  • Melanoma and Skin Cancers
  • Primary Brain Tumors
  • Head & Neck and Thyroid Cancers
  • Genitourinary Tumors (Prostate, Kidney, and Bladder)
  • New Developments in Radiation Oncology
  • State-Of-The-Art Molecular Diagnosis and Targeted
  • Therapy for Solid Tumors
  • Developmental Therapeutics and New Cancer Drugs
  • Healthcare Services & Survivorship
  • Pain Management, Supportive and Palliative Care
  • Integrative Medicine and Cancer
  • Management of Targeted Therapy and Chemotherapy
  • Complications Immunotherapy and Cancer
  • Cancer Genomics in Diagnosis, Prognosis, and Treatment

About Best of ASCO® 2018 Miami Symposium

Smart Snippet: Video
Datasource: ASCO and Dr Raez

Memorial Cancer Institute’s Best of ASCO® 2018 Miami Symposium, a program licensed by the American Society of Clinical Oncology (ASCO), is designed to present practicing clinicians, surgeons, radiation oncologists and other healthcare professionals with the most recent abstracts and guidelines presented at the 2018 American Society of Clinical Oncology Annual Meeting.

The goal of this educational session is to incorporate recent advances in the treatment of cancer into clinical practice. National and International faculty will review state of the art developments in hematology, oncology, surgical oncology and radiation oncology. Participants will have the opportunity for audience interaction with the faculty. Memorial Cancer Institute (MCI) is a leading Cancer Institute in Florida and is part of the Memorial Health Care System, the third largest public health care system in America. This important event is partnering with the Florida Society of Clinical Oncology (FLASCO), Florida Cancer Specialists & Research Institute (FCS), Nova Southeastern University’s College of Pharmacy, and the Herbert Wertheim College of Medicine at Florida International University (FIU).

2018 Educational Objectives

Smart Snippet: Video
Datasource: Best of ASCO Immuno

At the completion of this symposium the participants should be able to:

  • Review advances in clinical and translational cancer research as presented during the 2018 ASCO annual meeting
  • Evaluate the role of new diagnostic techniques and therapeutic approaches as applied to the care and management of patients with cancer
  • Discuss the latest clinical trials that have influenced the changes in standards of oncology care both in the U.S. and globally
  • Obtain a comprehensive and state of the art review of hematology, oncology, surgical oncology, and radiation oncology developments
  • Implement new patient management and supportive care strategies or revise existing ones